Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores.

Autor: Krishna G Aragam, Umesh U Tamhane, Eva Kline-Rogers, Jin Li, Keith A A Fox, Shaun G Goodman, Kim A Eagle, Hitinder S Gurm

Publikováno v: PLoS ONE, Vol 4, Iss 11, p e7947 (2009)

BackgroundThe Thrombolysis in Myocardial Infarction (TIMI) risk scores for Unstable Angina/Non-ST-elevation myocardial infarction (UA/NSTEMI) and ST-elevation myocardial infarction (STEMI) and the Global Registry of Acute Coronary Events (GRACE) risk

Externí odkaz: https://doaj.org/article/51b3d8bcbf0947bca907f131dcf90b65

Efficacy of Cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials

Autor: Umesh U. Tamhane, Pascal Meier, Hitinder S. Gurm, Kang Yin Chen, Seung-Woon Rha, Stanley Chetcuti, Michael P. Grossman

Publikováno v: EuroIntervention. 5:384-393

Aims: Cilostazol has been associated with reduction in restenosis in patients undergoing coronary and peripheral arterial angioplasty. Our objective was to evaluate the impact of cilostazol on restenosis in patients undergoing contemporary PCI with b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9bc9e8c94c8145f21e1588d1e3fa0a4b
https://doi.org/10.4244/v5i3a60

The chimeric monoclonal antibody abciximab: a systematic review of its safety in contemporary practice

Autor: Umesh U. Tamhane, Hitinder S. Gurm

Publikováno v: Expert Opinion on Drug Safety. 7:809-819

Abciximab is a monoclonal antibody that prevents platelet aggregation by blocking platelet glycoprotein (GP) IIb/IIIa receptor.To study the safety profile of this agent in contemporary clinical practice.We evaluated efficacy and safety end points (ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b50d45309413c05ecb4dcac148a4e21b
https://doi.org/10.1517/14740330802500353

Temporal Trends in Antiplatelet/Antithrombotic Use in Acute Coronary Syndromes and In-Hospital Major Bleeding Complications

Autor: Umesh U. Tamhane, Apurva A. Motivala, Eva Kline Rogers, Kim A. Eagle, Mauro Moscucci, Jin Li, Hitinder S. Gurm, James B. Froehlich, Fadi Saab

Publikováno v: The American Journal of Cardiology. 100:1359-1363

Antithrombotic and antiplatelet agents are essential for the management of patients with acute coronary syndromes (ACSs). These pharmacologic agents have the potential for increased risk of bleeding. It is not clear if the increased uptake of these t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f8e7d5f067d270cf035063d78ae6910
https://doi.org/10.1016/j.amjcard.2007.06.023

Does simplicity compromise accuracy in ACS risk prediction?:A retrospective analysis of the TIMI and GRACE risk scores

Autor: Keith A.A. Fox, Umesh U. Tamhane, Hitinder S. Gurm, Jin Li, Shaun G. Goodman, Kim A. Eagle, Krishna G. Aragam, Eva Kline-Rogers

Publikováno v: Aragam, K G, Tamhane, U U, Kline-Rogers, E, Li, J, Fox, K A A, Goodman, S G, Eagle, K A & Gurm, H S 2009, ' Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores ', PLoS ONE, vol. 4, no. 11, e7947 . https://doi.org/10.1371/journal.pone.0007947
PLoS ONE
PLoS ONE, Vol 4, Iss 11, p e7947 (2009)

BackgroundThe Thrombolysis in Myocardial Infarction (TIMI) risk scores for Unstable Angina/Non-ST-elevation myocardial infarction (UA/NSTEMI) and ST-elevation myocardial infarction (STEMI) and the Global Registry of Acute Coronary Events (GRACE) risk

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71cc906839ccc762ed06c1563082b55e
https://www.pure.ed.ac.uk/ws/files/8138416/Does_simplicity_compromise_accuracy_in_ACS_risk_prediction.pdf